Breaking News

AMRI Acquires Gadea Pharmaceutical

Expands API portfolio with specialty and generic APIs and establishes strong European ops

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AMRI has acquired all outstanding shares of Gadea Pharmaceutical Group, a privately-held company in Valladolid, Spain, specializing in technically complex APIs and finished drug product, for $174 million.   Gadea’s Crystal Pharma division significantly expands AMRI’s API portfolio, adding a portfolio of specialty and generic APIs. Crystal also brings sterile API capabilities with ophthalmic and parenteral suspension dosage forms and prefilled syringe and lyophilization capability. ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters